Tanezumab improves scores for pain, function in osteoarthritis

(HealthDay)—For patients with osteoarthritis (OA) of the knee or hip, tanezumab is associated with significant improvements in pain and physical function versus placebo, according to a study published in the July 2 issue of the Journal of the American Medical Association.

* This article was originally published here